The patient's attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of cystocele, rectocele, enterocele, urinary incontinence and retention.
It was reported that after implant, the patient experienced rectocele, enterocele, urinary tract infection, vaginal infection, urinary incontinence, urinary retention, cystocele, pain, vaginal discharge, bleeding, clotting disorders, neuromuscular disorder, hypertension, stroke, heart attack, brain injury.
Post-operative patient treatment included medication, hospitalization, incontinence pad use.
|